A weekly Saturday night financial show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators. This week’s show includes commentary on the Fed’s first and only rate hike in 2016, Eli Lilly’s long-acting Basal Insulin that’s now available in the US, takeover rumors circulating about Qorvo, Protalix Biotherapeutics $24 million order to treat Gaucher patients in Brazil, the FDA approval of Vericel’s Maci for the repair of cartilage defects of the knee, Silicon Motion’s supplying of SSD solutions to the Alibaba Group, and more.
Latest posts by Lance Jepsen
- Sarepta Therapeutics In Strong Uptrend From Exondys 51 - November 19, 2017
- Top 16 Companies With Earnings and Revenue Beats - November 19, 2017
- Top Weekend News Stories November 19 2017 - November 19, 2017